BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses

Phillipe D. O'Brien, Junguk Hur, John M. Hayes, Carey Backus, Stacey A. Sakowski, Eva L. Feldman

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Given the lack of treatments for diabetic neuropathy (DN), a common diabetic complication, accurate disease models are necessary. Characterization of the leptin-deficient BTBR ob/. ob mouse, a type 2 diabetes model, demonstrated that the mice develop robust diabetes coincident with severe neuropathic features, including nerve conduction deficits and intraepidermal nerve fiber loss by 9 and 13. weeks of age, respectively, supporting its use as a DN model. To gain insight into DN mechanisms, we performed microarray analysis on sciatic nerve from BTBR ob/. ob mice, identifying 1503 and 642 differentially expressed genes associated with diabetes at 5 and 13. weeks, respectively. Further analyses identified overrepresentation of inflammation and immune-related functions in BTBR ob/. ob mice, which interestingly were more highly represented at 5. weeks, an observation that may suggest a contributory role in DN onset. To complement the gene expression analysis, we demonstrated that protein levels of select cytokines were significantly upregulated at 13. weeks in BTBR ob/. ob mouse sciatic nerve. Furthermore, we compared our array data to that from an established DN model, the C57BKS db/. db mouse, which reflected a common dysregulation of inflammatory and immune-related pathways. Together, our data demonstrate that BTBR ob/. ob mice develop rapid and robust DN associated with dysregulated inflammation and immune-related processes.

Original languageEnglish (US)
Pages (from-to)348-355
Number of pages8
JournalNeurobiology of Disease
Volume73
DOIs
StatePublished - Jan 1 2015

Fingerprint

Neurological Models
Diabetic Neuropathies
Gene Expression
Sciatic Nerve
Inflammation
Neural Conduction
Diabetes Complications
Microarray Analysis
Leptin
Nerve Fibers
Type 2 Diabetes Mellitus
Observation
Cytokines

Keywords

  • Cytokine
  • Diabetic neuropathy
  • Functional enrichment
  • Gene expression analysis
  • Inflammation
  • Leptin
  • Matrix metalloproteinase
  • Mouse model
  • Obesity
  • Type-2 diabetes

ASJC Scopus subject areas

  • Neurology

Cite this

BTBR ob/ob mice as a novel diabetic neuropathy model : Neurological characterization and gene expression analyses. / O'Brien, Phillipe D.; Hur, Junguk; Hayes, John M.; Backus, Carey; Sakowski, Stacey A.; Feldman, Eva L.

In: Neurobiology of Disease, Vol. 73, 01.01.2015, p. 348-355.

Research output: Contribution to journalArticle

O'Brien, Phillipe D. ; Hur, Junguk ; Hayes, John M. ; Backus, Carey ; Sakowski, Stacey A. ; Feldman, Eva L. / BTBR ob/ob mice as a novel diabetic neuropathy model : Neurological characterization and gene expression analyses. In: Neurobiology of Disease. 2015 ; Vol. 73. pp. 348-355.
@article{5b379840de2a44be8ce665417044d867,
title = "BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses",
abstract = "Given the lack of treatments for diabetic neuropathy (DN), a common diabetic complication, accurate disease models are necessary. Characterization of the leptin-deficient BTBR ob/. ob mouse, a type 2 diabetes model, demonstrated that the mice develop robust diabetes coincident with severe neuropathic features, including nerve conduction deficits and intraepidermal nerve fiber loss by 9 and 13. weeks of age, respectively, supporting its use as a DN model. To gain insight into DN mechanisms, we performed microarray analysis on sciatic nerve from BTBR ob/. ob mice, identifying 1503 and 642 differentially expressed genes associated with diabetes at 5 and 13. weeks, respectively. Further analyses identified overrepresentation of inflammation and immune-related functions in BTBR ob/. ob mice, which interestingly were more highly represented at 5. weeks, an observation that may suggest a contributory role in DN onset. To complement the gene expression analysis, we demonstrated that protein levels of select cytokines were significantly upregulated at 13. weeks in BTBR ob/. ob mouse sciatic nerve. Furthermore, we compared our array data to that from an established DN model, the C57BKS db/. db mouse, which reflected a common dysregulation of inflammatory and immune-related pathways. Together, our data demonstrate that BTBR ob/. ob mice develop rapid and robust DN associated with dysregulated inflammation and immune-related processes.",
keywords = "Cytokine, Diabetic neuropathy, Functional enrichment, Gene expression analysis, Inflammation, Leptin, Matrix metalloproteinase, Mouse model, Obesity, Type-2 diabetes",
author = "O'Brien, {Phillipe D.} and Junguk Hur and Hayes, {John M.} and Carey Backus and Sakowski, {Stacey A.} and Feldman, {Eva L.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.nbd.2014.10.015",
language = "English (US)",
volume = "73",
pages = "348--355",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - BTBR ob/ob mice as a novel diabetic neuropathy model

T2 - Neurological characterization and gene expression analyses

AU - O'Brien, Phillipe D.

AU - Hur, Junguk

AU - Hayes, John M.

AU - Backus, Carey

AU - Sakowski, Stacey A.

AU - Feldman, Eva L.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Given the lack of treatments for diabetic neuropathy (DN), a common diabetic complication, accurate disease models are necessary. Characterization of the leptin-deficient BTBR ob/. ob mouse, a type 2 diabetes model, demonstrated that the mice develop robust diabetes coincident with severe neuropathic features, including nerve conduction deficits and intraepidermal nerve fiber loss by 9 and 13. weeks of age, respectively, supporting its use as a DN model. To gain insight into DN mechanisms, we performed microarray analysis on sciatic nerve from BTBR ob/. ob mice, identifying 1503 and 642 differentially expressed genes associated with diabetes at 5 and 13. weeks, respectively. Further analyses identified overrepresentation of inflammation and immune-related functions in BTBR ob/. ob mice, which interestingly were more highly represented at 5. weeks, an observation that may suggest a contributory role in DN onset. To complement the gene expression analysis, we demonstrated that protein levels of select cytokines were significantly upregulated at 13. weeks in BTBR ob/. ob mouse sciatic nerve. Furthermore, we compared our array data to that from an established DN model, the C57BKS db/. db mouse, which reflected a common dysregulation of inflammatory and immune-related pathways. Together, our data demonstrate that BTBR ob/. ob mice develop rapid and robust DN associated with dysregulated inflammation and immune-related processes.

AB - Given the lack of treatments for diabetic neuropathy (DN), a common diabetic complication, accurate disease models are necessary. Characterization of the leptin-deficient BTBR ob/. ob mouse, a type 2 diabetes model, demonstrated that the mice develop robust diabetes coincident with severe neuropathic features, including nerve conduction deficits and intraepidermal nerve fiber loss by 9 and 13. weeks of age, respectively, supporting its use as a DN model. To gain insight into DN mechanisms, we performed microarray analysis on sciatic nerve from BTBR ob/. ob mice, identifying 1503 and 642 differentially expressed genes associated with diabetes at 5 and 13. weeks, respectively. Further analyses identified overrepresentation of inflammation and immune-related functions in BTBR ob/. ob mice, which interestingly were more highly represented at 5. weeks, an observation that may suggest a contributory role in DN onset. To complement the gene expression analysis, we demonstrated that protein levels of select cytokines were significantly upregulated at 13. weeks in BTBR ob/. ob mouse sciatic nerve. Furthermore, we compared our array data to that from an established DN model, the C57BKS db/. db mouse, which reflected a common dysregulation of inflammatory and immune-related pathways. Together, our data demonstrate that BTBR ob/. ob mice develop rapid and robust DN associated with dysregulated inflammation and immune-related processes.

KW - Cytokine

KW - Diabetic neuropathy

KW - Functional enrichment

KW - Gene expression analysis

KW - Inflammation

KW - Leptin

KW - Matrix metalloproteinase

KW - Mouse model

KW - Obesity

KW - Type-2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84909979541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909979541&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2014.10.015

DO - 10.1016/j.nbd.2014.10.015

M3 - Article

C2 - 25447227

AN - SCOPUS:84909979541

VL - 73

SP - 348

EP - 355

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -